Seroprevalence of anti-N-methyl-d-aspartate receptor antibodies in women with ovarian teratoma

Journal of Neurology

Volumn 260, Issue 11, 2013, Pages 2831-2835

  Mangler, Mandy ^a   Trebesch De Perez, Isabel ^a   Teegen, Bianca ^b   Stöcker, Winfried ^b   Prüss, Harald ^a   Meisel, Andreas ^a   Schneider, Achim ^a   Vasiljeva, Jekaterina ^a   Speiser, Dorothee ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Experimental Immunology   (Germany)

Author keywords

Anti N methyl d aspartate receptor antibodies; NMDA receptor encephalitis; Ovarian teratoma; Screening for anti N methyl d aspartate receptor autoantibodies

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GYNECOLOGIC SURGERY; GYNECOLOGICAL EXAMINATION; HUMAN; IMMUNOASSAY; LAPAROSCOPIC SURGERY; NEUROLOGIC EXAMINATION; OVARY TERATOMA; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROPREVALENCE; TRANSVAGINAL ECHOGRAPHY;

ADULT; ANIMALS; AUTOANTIBODIES; CEREBELLUM; FEMALE; HAPLORHINI; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; SEROEPIDEMIOLOGIC STUDIES; TERATOMA;

EID: 84889560037     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7074-0     Document Type: Article

References (29)

1. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25-36
2. Tachibana N, Shirakawa T, Ishii K, Takahashi Y, Tanaka K, Arima K, Yoshida T, Ikeda S (2010) Expression of various glutamate receptors including N-methyl-d-aspartate receptor (NMDAR) in an ovarian teratoma removed from a young woman with anti-NMDAR encephalitis. Inter Med 49:2167-2173
3. Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J (2009) Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol 118(6):737-743
4. Uchino A, Iizuka T, Urano Y, Arai M, Hara A, Hamada J, Hirose R, Dalmau J, Mochizuki H (2011) Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med 50(6):627-630
5. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70(7):504-511
6. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63-74 Review
7. Tumbi A, Gilani A, Scarff JR, Kaur G, Lippmann S (2011) Anti-N-methyl-d encephalitis. Innov Clin Neurosci 8(9):24-25
8. Ryan SA, Costello DJ, Cassidy EM, Brown G, Harrington HJ, Markx S (2013) Anti-NMDA receptor encephalitis: a cause of acute psychosis and catatonia. J Psychiatr Pract 19(2):157-161. doi: 10.1097/01.pra.0000428562.86705.cd
9. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091-1098
10. Iizuka T, Yoshii S, Kan S, Hamada J, Dalmau J, Sakai F, Mochizuki H (2010) Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 257(10):1686-1691. doi: 10.1007/s00415-010-5604-6
11. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J (2007) A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 3(5):291-296
12. Spiegel DR, Zaki N (2013) A case of new onset psychosis in a young woman with minimal response to risperidone, ultimately diagnosed with N-methyl-d-aspartate receptor encephalitis. Clin Schizophr Relat Psychoses:1-20. (Epub ahead of print)
13. Dericioglu N, Vural A, Acar P, Agayeva N, Ismailova V, Kurne A, Saka E, Arsava EM, Topcuoglu MA (2013) Antiepileptic treatment for anti-NMDA receptor encephalitis: the need for video-EEG monitoring. Epileptic Disord 15(2):166-170. doi: 10.1684/epd.2013.0566
14. Wandinger KP, Saschenbrecker S, Stoecker W, Dalmau J (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 231(1-2):86-91
15. Prüss H, Dalmau J, Arolt V, Wandinger K-P (2010) Anti-NMDA-Rezeptor-Enzephalitis. Ein interdisziplinäres Krankheitsbild. Nervenarzt 81:396-408
16. Boeck AL, Logemann F, Krauß T, Hussein K, Bültmann E, Trebst C, Stangel M (2013) Ovarectomy despite negative imaging in anti-NMDA receptor encephalitis: effective even late. Case Rep Neurol Med 2013:843192. doi: 10.1155/2013/843192
17. Batra R, Pang Y, Friedman MT (2012) Therapeutic plasma exchange in anti-N-methyl-d-aspartate-receptor (anti-NMDA-R) encephalitis associated with benign ovarian teratoma. J Clin Apher 27(4):227-228. doi: 10.1002/jca.21212 No abstract available
18. Kitada M, Suzuki H, Ichihashi J, Mitsui Y, Tanaka K, Kusunoki S (2011) Dramatic improvement in two cases of anti-NMDA receptor encephalitis after immunomodulating therapy. Rinsho Shinkeigaku 51(9):683-687 Japanese
19. Peery HE, Day GS, Dunn S, Fritzler MJ, Prüss H, De Souza C, Doja A, Mossman K, Resch L, Xia C, Sakic B, Belbeck L, Foster WG (2012) Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev 11:863-872
20. Wandinger KP, Klingbeil C, Gneiss C, Waters P, Dalmau J, Saschenbrecker S, Borowski K, Deisenhammer F, Vincent A, Probst C, Stöcker W () New serological markers for the differential diagnosis of autoimmune limbic encephalitis. Laboratoriumsmedizin. Band 0, Heft 0, Seiten, ISSN (online) 1439-0477, ISSN (print) 0342-3026. doi: 10.1515/jlm.2011.059et
21. Stöcker W, Saschenbrecker S, Rentzsch K, Komorowski L, Probst C (2013) Autoantikörperdiagnostik in der Neurologie mittels nativer und rekombinanter Antigensubstrate. Der Nervenarzt 84(4):471-476
22. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, Sangha N, Martinez-Lage M, Dalmau J (2011) Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 77:589-593
23. Titulaer MJ, Kayser MS, Dalmau J (2013) Prevalence and treatment of anti-NMDA receptor encephalitis - authors' reply. Lancet Neurol 12:425-426
24. Irani SR, Bera K, Waters P et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655-1667
25. Steiner J, Walter M, Glanz W et al (2013) Increased prevalence of diverse N-methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-d-aspartate glutamate receptor encephalitis. JAMA psychiatry 70(3):271-278. doi: 10.1001/2013.jamapsychiatry.86
26. Prüss H, Finke C, Höltje M et al (2012) N-methyl-d-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72(6):902-911. doi: 10.1002/ana.23689
27. Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, Stoecker W, Wandinger KP (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75(19):1735-1739
28. Ella Wotzke Dissertation an der Rheinischen Friedrich-Wilhelms- Universität Bonn "Häufigkeit und Phänotyp neurologischer und psychiatrischer Symptome bei Patientinnen mit ovariellen Teratomen: Eine Fragebogenstudie". http://hss.ulb.uni-bonn.de/2011/2449/2449.pdf
29. Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, Rossi JE, Bien C (2009) Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66(4):458-464. doi: 10.1001/archneurol. 2009.5